These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21603789)
1. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient. Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789 [TBL] [Abstract][Full Text] [Related]
2. Moyamoya syndrome and neurofibromatosis type 1. Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383 [TBL] [Abstract][Full Text] [Related]
3. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient. Serafini NB; Serafini CB; Vinhas AS; Godinho MB An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453 [TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 associated with moyamoya syndrome in children. Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170 [TBL] [Abstract][Full Text] [Related]
5. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626 [TBL] [Abstract][Full Text] [Related]
6. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy. Lee ML; Chang TM; Yang RC; Yang AD; Chen M Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487 [TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis associated with moyamoya arteriopathy and fusiform aneurysm: case report]. Siqueira Neto JI; Silva GS; De Castro JD; Santos AC Arq Neuropsiquiatr; 1998 Dec; 56(4):819-23. PubMed ID: 10029888 [TBL] [Abstract][Full Text] [Related]
8. Scoliosis Secondary to Neurofibromatosis Type I Combined With Moyamoya Syndrome: A Case Report. Zhang H; Luo Y; Guo D; Yao Z; Liu H; Zhang X JBJS Case Connect; 2022 Jul; 12(3):. PubMed ID: 36137072 [TBL] [Abstract][Full Text] [Related]
9. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Barrall JL; Summers CG Surv Ophthalmol; 1996; 40(6):500-4. PubMed ID: 8724642 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1 association with moyamoya disease. Koc F; Yerdelen D; Koc Z Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213 [TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1. Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous presentation of malignant peripheral nerve sheath tumor and moyamoya disease associated with neurofibromatosis type 1 in a child. Yoo SY; Hwang SM; Lee MK; Jo DS; Hwang PH Turk J Pediatr; 2015; 57(2):202-5. PubMed ID: 26690608 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome. Witmer MT; Levy R; Yohay K; Kiss S JAMA Ophthalmol; 2013 Apr; 131(4):538-9. PubMed ID: 23430230 [No Abstract] [Full Text] [Related]
14. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya. Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345 [TBL] [Abstract][Full Text] [Related]
15. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1. Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809 [TBL] [Abstract][Full Text] [Related]
16. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome. Tan RM; Chng SM; Seow WT; Wong J; Lim CC Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511 [TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature. Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349 [TBL] [Abstract][Full Text] [Related]
18. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience. Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438 [TBL] [Abstract][Full Text] [Related]
19. Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort. Bouchaala W; Laroussi S; Mzid Y; Maaloul I; Jallouli O; Zouari S; Ben Nsir S; Mnif Z; Kammoun F; Triki C Pediatr Neurol; 2024 Jan; 150():3-9. PubMed ID: 37925769 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1. Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]